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Neurotoxic Effects of Gasoline and Gasoline
Constituents
by Thomas M. Burbacher
This overview was developed as part ofa symposium on noncancer end points ofgasoline and key gasoline
components. The specific components included are methyl tertiary butyl ether, ethyl tertiary butyl ether,
tertiary amyl methyl ether, butadiene, benzene, xylene, toluene, methyl alcohol, and ethyl alcohol. The
overview focuses on neurotoxic effects related to chronic low-level exposures. A few general conclusions and
recommendations can be made based on the results ofthe studies to date. a) All the compounds reviewed are
neuroactive and, as such, should be examined fortheir neurotoxicity. b) For mostofthe compounds, there is a
substantial margin ofsafetybetweenthecurrentpermissible exposure levels andlevelsthatwouldbeexpected
tocauseovertsignsofneurotoxicityin humans.This isnotthecaseforxylene,toluene, andmethanol,however,
where neurologic effects are observed at or below the current Threshold Limit Value. c) For most of the
compounds, the relationship between chronic low-level exposure and subtle neurotoxic effects has not been
studied.Studiestherefore shouldfocus onexaminingthedose-response relationshipbetweenchroniclow-level
exposure and subtle changes in central nervous system function.
Introduction
This overview was developed as part of a symposium on
noncancer end points ofgasoline and key gasoline constit-
uents. The specific constituents included in the overview
are methyl tertiary butyl ether, ethyl tertiary butyl ether,
tertiary amyl methyl ether, butadiene, benzene, xylene,
toluene, methyl alcohol, and ethyl alcohol. The overview is
notmeantto serve as anexhaustivereviewoftheliterature
for all compounds. Instead, certain examples of the neu-
rotoxic effects reported foreach compound are included in
the context of a discussion of a dose-response analysis or
calculation of a no-observable-adverse-effect level
(NOAEL) forhuman neurotoxic effects due to chronic low-
level occupational or environmental exposure. Finally, the
overview does not include studies of chemical mixtures
other than gasoline. The focus for this overview is on
specific key components ofgasoline.
Gasoline
The effects associated with the intentional use of gas-
oline as an intoxicant (gasoline sniffing) are commonly
neurologic in nature and include ataxia, tremor, and an
acute or subacute encephalopathic syndrome [see Forten-
berry for a review (1)].
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Occupational exposure to gasoline has been associated
with numerous signs of neurotoxicity. Significant effects
onintellectualcapacity,psychomotorandvisuomotorfunc-
tion, immediate and delayed memory, and an increased
proportionate mortality ratio (PMR) due to mental and
psychoneurotic conditions have beenreported forgasoline
service stationworkers (2,3). Symptoms such asheadache,
fatigue, loss of memory, and giddiness have also been
reported (4). Neurological effects (dizziness, headache)
have been reported in laboratory studies ofhuman volun-
teers exposed to gasoline vapor. These effects were
observed at a concentration of 2600 ppm but not at con-
centrations of1000 ppm and below (5,6).
In animals, acute exposure of dogs to high concentra-
tions of gasoline have been associated with neurologic
effects at 10,000 ppm and death at 25,000 ppm (7). A
preliminarystudyofratsexposed to1500ppmgasolinefor
6 hr/day, 5 days/week for up to 18 months demonstrated
more extensive axonal dystrophy and degeneration in the
distal gracile tract of the spinal cord as well as abnor-
malities ofanterior horn cells (8). Chronic exposure, 6 hr/
dayfor5days/weekfor90days, ofrats andmonkeysto400
ppm and 1500 ppm gasoline, however, did not produce
overt neurotoxicity or changes in visual evoked responses
(9). In another study, rats and mice exposed to 50, 275, or
1500 ppm gasoline for 6 hr/day, 5 days/week for up to 113
weeks also failed to show signs ofovertneurotoxicity (10).
A study ofthe effects ofexposure to unleaded gasoline on
thehyp,othalamo-pituitary-thyroid-adrenal systemin rats
has indicated a significant increase in serum cortico-
sterone and adrenal catecholamines and a decrease in
hypothalamic noradrenaline. These effects were observedT M. BURBACHER
only after 60 days of exposure to > 600 ppm unleaded
gasoline in air for 8 hr/day, 5 days/week. Effects were not
observed after 1, 3, 7, 14, or 30 days of exposure (11).
A summary of the neurotoxic effects reported for gas-
oline is shown in Table 1. Thus far, studies of human
exposures to gasoline have provided little data regarding
the actual level ofgasoline exposure. Although some expo-
suredata areavailableforthestudiesusinganimalmodels,
the smallnumberofstudies andthe useofdifferentdosing
schedules and neurotoxic end points make a dose-
response analysis forthevarious end points reported very
difficult. At this time, sufficient data are not available to
support calculating a no-observed-adverse-effect level
(NOAEL) for the neurotoxic effects of chronic low-level
gasoline exposure.
Methyl Tertiary Butyl Ether
Therehavebeen noreports concerningthetoxic (includ-
ing neurotoxic) effects of methyl tertiary butyl ether
(MTBE) in humans due to occupational exposure. The use
ofMTBE as a therapeutic agent for dissolving gallstones
(12) has provided information regarding the side effects in
humans of MTBE administered by infusion. These stud-
ies, however, do notprovide datarelevant to the evaluation
of MTBE neurotoxicity.
Studies in animals have not provided evidence of overt
neurotoxicity due to MTBE exposure atairconcentrations
from 100 ppm to 3000 ppm MTBE (13-15). In addition,
gross teratogenic effects were not observed in rats and
mice at air concentrations from 250 ppm to 2500 ppm
MTBE (16-18). A decrease in offspring viability, however,
has been reported at air concentrations of 1000 ppm and
2500 ppm (19).
More subtle neurotoxic effects due to MTBE exposure
havebeenreportedintwostudiessponsoredbytheMethyl
Tertiary Butyl Ether Task Force (20,21). The effects of a
single 6-hr exposure to MTBE and exposure for13 days, 6
hr/day were examined. Both studies used rats and MTBE
air concentrations of8000, 4000, 800, and 0 ppm. Several
neurobehavioral effects were reported at all levels ofexpo-
sure inboth studies. The most consistenteffects related to
Table 1. Summary ofthe neurotoxic effects ofgasoline.
Humans
Chronic gasoline sniffing
Ataxia, tremor, encephalopathic syndrome
Occupational exposure
Headache, fatigue, memory loss, psychomotor and visuomotor dys-
function
Laboratory studies
Headache, dizziness at air concentrations above 2600 ppm
Animals
Acute exposure
Tremors and convulsions atairconcentrations above580 ppm, severe
neurologic signs at 10,000 ppm, death at 25,000 ppm
Chronic exposure
No overt signs of neurotoxicity at air concentrations of 1500 ppm,
degeneration in spinal cord and anterior horn cells at 1500 ppm,
increase in serum corticosterone and adrenal catecholamines and
decrease in hypothalamic noradrenaline at 650 ppm
T'able 2. Summary ofthe neurotoxic effects of
methyl tertiary butyl ether in animals.
Acute exposure
Reduction in activity at 8000 ppm, increase in activity at 4000 and 800
ppm
Chronic exposure
Noovertneurotoxicityatairconcentrations from100ppmto3000ppm,
no overt teratogenic effects from 250 to 2500 ppm, decreased
offspringviabilityat1000and2500ppm,reductioninactivityat8000
ppm, increase in activity at 4000 and 800 ppm
MTBE exposurewere those on activity.Athigherlevels of
exposure (8000 ppm), a reduction in overall activity, or a
sedation effect, was observed. Atthe lowerconcentrations
tested (4000 and 800 ppm), an increase in overall activity
was observed. The authors stated that the increase in
overall activity observed at the lower MTBE air con-
centrations tested (4000 and 800 ppm) "may reflect an
exposure-related stimulant effect" (20).
A summary of the neurotoxic effects reported for
MTBE is showninTable2. To date, studiesofoccupational
exposures of workers to MTBE have not been reported.
The two MTBE Task Force studies using rats do provide
some dose-response data for MTBE effects in adult ani-
mals. These studies do not report a NOAEL of exposure
forMTBE. Central nervous systemstimulanteffectswere
observed at the lowest dose studied.
Ethyl Tertiary Butyl Ether
Reports concerningthe neurotoxic effects ofethylterti-
ary butyl ether (ETBE) could not be found. ETBE, like
MTBE, can be used as a gasoline antiknock additive. To
date,production ofETBE isverylow; however,production
islikelytoincreasebecauseETBE hasseveraladvantages
over MTBE for use in reformulated gasoline (22).
Tertiary Amyl Methyl Ether
Only one report concerning the toxic effects oftertiary
amylmethylether(TAME) couldbefound (23).This study
examinedtheeffects of125, 500, or1000mL/kg/dayTAME
administered to rats by gavage 7 days/week for 29 days.
General observations for overtsigns ofneurotoxicitywere
included throughout the dosing period. The results ofthe
observations did notindicatethepresenceofovertsignsof
neurotoxicity. Only a few of the observations were not
listed as "within normallimits." Fourofthe animals inthe
1000 mL/kg/day dosage group died during the study. Two
deaths were related to dosingaccidents, and the other two
were related to exposure to TAME.
Fewconclusions canbe drawnregardingthe neurotoxic
effects ofTAME fromthesinglestudyavailableforreview.
In rats, oral doses of 1000 mL/kg/day TAME increased
mortality. Eight doses of 500 and 125 mL/kg/day did not
increase mortality or cause overt signs of neurotoxicity.
Studies of humans or animals focusing on TAME neu-
rotoxicity have not been reported.
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Butadiene
Neurotoxic effects in humans due to exposure to buta-
diene have not been reported to date. Studies using ani-
mals, however, have reported species-specific teratogenic
effects due to butadiene exposure (24,25). In mice, expo-
sure to 1,3-butadiene for 6 hr/day on gestation days 6-15
has been related to a decrease in maternal, fetal, and
placental weights and an increase in the incidence offetal
variations. Reduced fetalweights formales were observed
at the lowest exposure concentration (40 ppm). The remain-
ing effects were observed at 200 and 1000 ppm concentra-
tions. In rats, reduced maternal body weights at 1000 ppm
butadiene were the only effects observed. No signs of
maternal neurotoxicity were observed in either study.
Possible offspring neurotoxic effects were not examined.
Differences in the pharmacokinetics of butadiene have
been reported for rats and mice (26). These differences
result in an accumulation ofepoxybutene, a primary reac-
tive intermediate of butadiene, in mice but not in rats. A
reported increased susceptibility of mice to butadiene
carcinogenesis has been related to these differences (26).
The species-specific teratogenic effects reviewed above
may also be related to these pharmacokinetic differences.
Like TAME, veryfew conclusions canbe drawn regard-
ingthe potential neurotoxicity ofbutadiene from the stud-
ies avilable to date. Air concentrations ofbutadiene as low
as40 ppmhavebeen associatedwithreducedfetalweights
for mice. Air concentrations as high as 1000 ppm were not
associated with overt fetal effects for rats. Studies
focusing on the neurotoxic effects ofbutadiene forhumans
or animals have not been reported.
Benzene
The primary effects associated with chronic benzene
exposure in humans and animals are anemia and leuko-
penia (27). Neurotoxic effects in humans due to benzene
exposure have not been reported.
In animals, overt neurotoxic effects, usually signs of
narcosis, have been reported at air concentrations ofben-
zene above 4000 ppm. Benzene exposures above 10,000
ppm may result in death (28). Maternal inhalation expo-
sureto100-2200 ppmbenzenefor6hr/dayfromday6to15
of gestation did not result in overt neurotoxicity in adult
rats, although maternal and fetal weight effects and fetal
skeletal effects were observed(29). Subtleneurobehavioral
effects in animals due to benzene exposure have been
reported. Consistent and significant changes in mouse
milk-licking responses have been reported after approx-
imately 1 week of inhalation exposure to benzene at 300
ppm (27). Effects on adult rat motor activity and a
decreased response to d-amphetamine challenge have
been associated with neonatal exposure to benzene via SC
injection at 550 mg/kg (30). Benzene neurochemical
effects, in animals, have also been reported. Increases in
the level ofcatecholamines invarious regions ofthe mouse
brain have been reported after exposure to benzene in
drinking water at 8 mg/kg/day (31).
Iable 3. Summary ofthe neurotoxic effects ofbenzene in animals.
Acute exposure
Narcosis at air concentrations above 4000 ppm, death at 10,000 ppm
Chronic exposure
No overt neurotoxicity at air concentrations between 100 and 2200
ppm, increase inmilk-lickingbehavior at300ppm,increase in motor
activity and decrease in response to d-amphetamine at 550 mg/kg
IP, increase in catecholamines at 8 mg/kg/day in drinking water
IP, intraperitoneal.
A summary ofthe neurotoxic effects reported for ben-
zene is shown in Table 3. The earliest indicators ofeffects
due tobenzene exposure inhumans and animals is anemia
and leukopenia. Although important neurotoxic effects
have been associated with benzene exposure in animals,
these effects are observed at exposure levels well above
those associated with hematologic changes.
Xylene
The neurologic effects due to short-term exposure to
xylene have been reported from laboratory studies of
human volunteers. The results of these studies indicated
that the odor threshold forxylene is approximately 1 ppm
(32). Brief exposure to approximately 70 ppm xylene did
not affect reaction time or short-term memory (33). Inha-
lation exposure at 90 ppm, however, caused deleterious
effects on reaction time, manual dexterity, body balance,
and EEG (34). Short-term exposure to xylene at 300 ppm
has been associated with a decrement in performance on
reaction time, memory span, and critical flicker fusion
tests (35). Exposureat100-400ppmalsocausedanimpair-
mentofbodybalance andincreasedreactiontime (36), and
eye irritation occurred at 460 ppm (32).
In animals, repeated exposures to air concentrations of
xylene in therange of200-2000 ppmhavebeen associated
witheffects onbehaviorand/orbrainchemistry. Exposure
to xylene for 4 hr/day for 3 consecutive days at 1600 ppm
increased motoractivityinrats (37). Changesindopamine
and noradrenaline levels and turnover in various regions
ofthe ratbrain have been observed afterxylene exposure
for 6 hr/day for 3 consecutive days at 2000 ppm (38).
Changesinneurotransmitters havealsobeenreportedafter
a 30-day exposure from 200 to 800 ppm (39). The earliest
neurochemical effect of xylene, a decrease in brain glu-
tathione, occurred after 5 days ofexposure at 50 ppm (40).
Asummaryoftheneurotoxiceffectsreportedforxylene
is shown in Table 4. The results ofstudies ofhumans and
animals indicate xylene neurotoxic effects below the cur-
rent TLV level of100 ppm. The results would predict that
occupational exposure at the TLV would adversely affect
humanperformance. Thelong-term effectsfromrepeated
exposures to xylene remain uncertain.
ITable 4. Summary ofthe neurotoxic effects ofxylene.
Humans
Acute exposure
Reducedreaction time,manualdexterity, disruption ofbodybalance
and EBG at air concentrations above 90 ppm
Animals
Chronic exposure
Increase in motor activity at 1600 ppm, changes in neurotransmitters
between 200 and 2000 ppm, increase in brain glutathione at 50 ppm
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Methanol
The deliberateingestion ofmethanol hasbeenrelated to
several toxic effects. The symptoms associated with meth-
anol intoxication include headache, dizziness, nausea,
vomiting, severe abdominal pain, and periodic breathing.
Coma and death from respiratory failure can occur in
severe cases. Several visual symptoms have also been
reported after methanol intoxication. These include
blurred vision, altered visual fields, and total blindness.
These symptoms are observed as a result of metabolic
acidosis, which develops as a result of an accumulation of
formic acid. Autopsies from lethal poisonings have indi-
cated degenerative changes in the basal ganglia. Sur-
vivors of severe poisonings sometimes display motor
distubances similar to Parkinsonism (41,42).
Prolonged occupational exposure to methanol has also
been associated with several toxic effects (43). Significant
increases in the prevalence of blurred vision, headaches,
dizziness, nausea, and skin problems were observed for
teacher's aidesexposedto duplicatingfluids of99%methyl
alcohol. Air concentrations of methyl alcohol near the
duplicating machines were well above the permissible
exposure limit time-weighted average of 200 ppm. Meth-
anol air concentrations as high as 3080 ppm were
observed. A recent study using human volunteers exam-
ined the effects of exposure to methanol vapor at 192 ppm
for 75 min (44). Several tests were administered to the 12
subjects before, during, and after the exposure. Although
performance on most tests was normal, a slight impair-
ment on a memory and concentration test and minor
changes in brain wave patterns in response to light and
sound were detected. The results from these tests were
within the range observed for the subjects without meth-
anol exposure. The significance of the changes observed
during methanol exposure, therefore, await further inves-
tigation.
In animals, metabolic acidosis and ocular toxicity have
been observed in nonhuman primates and folate-deficient
rats afterhigh-dose methanol exposure (45-48). Studies of
nonhuman primates have indicated that the minimum
lethal oral dose for methanol is approximately 3 g/kg. A
dose of2 mg/kg has been associated with metabolic acid-
osis and ocular toxicity. Several neurotoxic effects have
also been reported at lower levels ofmethanol exposure in
nonfolate-deficient rats. Rats exposed to 3 g/kg methanol
exhibited adisruption inthermoregulation dueto aninhib-
itory action of methanol on heat production pathways
(49,50). Altered auditory responses, which require tem-
poral resolution, have also been reported after methanol
exposure of rats at 0.25-3 g/kg (51). Studies of prenatal
exposure to methanol in rats havereported effects on fetal
development and postnatal behavior (52,53). Rats exposed
to methanol via inhalation at 26,000 ppm exhibited an
increase in maternal toxicity (unsteady gait) and fetal
malformations. Fetal malformations were also observed at
13,000 ppm exposure, althoughtheincrease was notsignif-
icant (52). Effects on newborn nesting behavior were
observed in ratoffspringatmaternal exposure of2.5g/kg/
day. These effects were observed without any signs of
Table 5. Summary ofthe neurotoxic effects ofmethanol.
Humans
Methanol ingestion
Headache, dizziness, visual symptoms, motor disturbances, meta-
bolic acidosis, degenerative changes in basal ganglia
Occupational exposure
Blurred vision, headache, dizziness at air concentrations between
300 and 3000 ppm
Animals
Acute exposure
Metabolic acidosis, ocular toxicity in nonhuman primates (2 mg/kg)
and folate deficient rats (3g/kg)
Chronic exposure
Disruption ofthermoregulation in normal rats at a dose of 3 g/kg,
altered auditory response between 0.25 and 3 g/kg, changes in
neurotransmitters at 3 g/kg, disruption of newborn nesting
behavior at 2.5 g/kg/day maternal exposure, unsteady gait at air
concentration of26,000 ppm
overt toxicityin the mothers or the offspring (53). Finally,
studies ofrats have also indicated effects ofmethanol on
brain chemistry (54-56). Changes in levels of dopamine,
norepinephrine, epinephrine, serotonin, and 5-hydroxy
indole acetic acid in various brain regions have been
reported after a single IP injection ofmethanol at 3 g/kg.
Asummary ofthe neurotoxic effects reportedformeth-
anol is shown in Thble 5. The recent study by Cook et al.
(44) provides preliminary evidence ofmethanol effects on
concentration, memory, and brain-wave patterns at an
exposure concentration of 192 ppm, which is below the
currentTLVformethanol (200ppm). Studiesusinganimal
models provide results for a narrow range of high doses
and do notprovide sufficient data to determine a NOAEL
ofchronic low-level exposure to methanol.
Toluene
The primary CNS effects associated with chronic
toluene abuse are ataxia and tremor, with cerebellar and
cerebral atrophy present in severe cases (57). Short-term
exposuretotolueneataboutthecurentTLV(100-150ppm)
affects performance on a number of tasks. Volunteers
exposed to toluene for 7 hr experienced alterations in
temperature and noise perception, an increase in feelings
of intoxication, lower scores on vigilance tests, altered
short-term memory, and poorer manual dexterity perfor-
mance. These effectswere notobserved at 75 ppm (58,59).
These effects are similar to those reported in studies of
occupational exposure to toluene (60-63); effects on neu-
ropsychological functioning are usually observed.
Short-termexposure totolueneinanimalshas alsobeen
associated with several behavioral effects. In rodents,
alterations in response rates, locomotion, and avoidance
learning have been observed (64). The effects on operant
response rates are dose dependent. Exposures at approx-
imately 1000 ppm have been shown to increase response
rates, whereas exposures at approximately 2000 ppm and
above decrease rates (65). Effects on locomotor activity
are also dose dependent. An increase in activity has been
reported after exposure at 5000 ppm, whereas a biphasic
response (increase then decrease) was observed athigher
exposure concentrations [10,000ppmand15,000ppm (66).]
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A decrease in shock avoidance responses has been
reported afterexposure to toluene above 1000 ppm. Expo-
sure at 500 ppm and below did not affect responding (67).
In monkeys, short-term exposure to toluene has been
shown to increase response time and decrease perfor-
mance on a cognitive task at 2000 ppm. Exposure to 100,
200, or 500 ppm, however, did not affectperformance (68).
The effects observed in the studies above appear tran-
sient. Response typically returns to normal soon afterthe
exposure has ended.
Several biochemical effects have been reported in stud-
ies of animals after short-term toluene exposure. These
studies typically used a design that includes a single
exposure to toluene orrepeated exposures overafewdays
before the sacrifice of the animal (immediately following
the last exposure). The neurochemical effects of toluene
after asingle IPinjection to rats at200, 400, or600mg/kg
include asignificant dose-dependentincrease in 5-hydrox-
ytryptamine (5-HT), a significant dose-dependent
increase in noradrenaline (NA) and 3-methoxy-4-
hydroxyphenyl-glycol (MHPG), and a significant dose-
dependent decrease in 5-hydroxyindoleacetic acid (5-
HIAA) in various regions of the brain (69). The neu-
rochemical effectsofshort-terminhaledtoluene at80,500,
1500, or 3000 ppm included a significant reduction in the
affinity in striatal [3H]spiperone-binding sites and in cor-
tical [3H]5-HT-binding sites at 3000 ppm, a decrease in
dopamine (DA) levels in the marginal zone ofthe nucleus
caudatus and anterior part of the nucleus accumbens, a
decrease in DA turnover in the marginal zone and the
medialandcentralpartoftheanteriornucleuscaudatusat
80ppm, and adose-dependent effect, from80to 1500ppm,
on I-adrenergic receptors (70,71).
Studies of chronic toluene exposure in animals have
reported numerous behavioral and biochemical effects.
Thesestudiestypicallyuseadesignthatincludesrepeated
exposures to toluene over aperiod from 1 week to several
months. The behavioral assessments usually take place
during toluene exposure. Some studies, however, examine
the nature of the behavioral effects by testing subjects
after the exposure has ended. Typically, biochemical stud-
ies are conducted immediately after the last exposure or
after the lastbehavioral assessment. Chronic exposure to
high concentrations ofinhaled toluene in rodents to simu-
late human toluene abuse is associated with alterations in
visual, auditory, somatosensory, and peripheral nerve
evoked potentials, locomotor activity, and motor coordina-
tion (72-75). A transient decrease in total sleep and an
increase in locomotor and drinking activity have been
reported during 2 weeks oftoluene exposure via IP injec-
tion at 200 mg/kg/day. Neurochemical changes were also
observed. Levels of5-HT and 5-HIAA were significantly
decreased, but MHPG, DOPAC and HVA concentrations
were significantlyincreased. Effectswere notobserved at
100mg/kg/day (76). Chronic exposure (4weeks) ofrats to
toluene via inhalation has also been associated with neu-
rochemical changes in various regions of the brain. A
significantdecreaseinamino-aciddecarboxylase(AAD) at
250 ppm and 1000 ppm, glutamic acid decarboxylase
(GAD) at 50 ppm, and receptor binding ofglutamate and
GABAbindingatalllevelsofexposurehavebeenreported.
In addition, a significant increase was observed in glu-
tamine synthetase activity (GLN-S) at 1000 ppm and
receptor binding of glutamate and GABA binding at 50
and 1000 ppm (77).
Developmental exposure to toluene has been associated
with severalbehavioral effects in exposed offspring. Fluid
consumption, maternal and infant mortality, weight gain,
eye and ear opening, and startle and surface-righting
responses were not affected by toluene exposure. Activity
in the open-field and rotorod performance, however, were
altered by toluene and nearly all of the exposed animals
were observed to have splayed hindlimbs (78).
A summary of the neurotoxic effects reported for
toluene is shown in Table 6. The data regarding toluene
neurotoxiceffectsindicatethatthecurrentTLVof100ppm
provides little or no margin of safety. In humans, short-
term exposure to toluene at about the TLV alters percep-
tionandlowersperformanceonmotorandcognitivetasks.
These effects are similar to those reported in studies of
occupational exposuretotoluene. In animalmodels, short-
term exposure to toluene below the TLV decreases
dopamine levels and turnover in the brain and selectively
increases the number and decreases the affinity of
,B-adrenergic receptors. Developmental exposure to
toluene alters activity and motor coordination.
Ethanol
In humans, some of the neurotoxic effects associated
with long-term alcohol abuse include anterograde and
retrograde amnesia, dementia, ataxia, dysarthria, and
peripheral-nerve disorders. Wernicke's syndrome and
Korsakoffs syndrome are associated with chronic alcohol
abuse primarily due to an alcohol-induced thiamine defi-
ciency. Histologic features of these syndromes include
microscopic lesions in the thalamus, hypothalamus, mes-
encephalon, andbrainstem aswell as cerebellar and corti-
cal lesions (79-82).
The fewstudies ofethanol effects afterinhalation expo-
sure have indicated that, in humans, the initial symptoms
Table 6. Summary ofthe neurotoxic effects oftoluene.
Humans
Toluene sniffing
Ataxia, tremor, cerebellar and cerebral atrophy
Occupational or short-term exposure
Reducedmanual dexterityandvigilance scores, short-termmemory
loss, disruption in perception at air concentrations above 100 ppm
Animals
Short-term exposure
Dose-dependent changes in response rates at air concentrations of
1000 ppm and above,increase in activity at5000ppm, decrease in
activity at 15,000 ppm, decrease in shock avoidance responses at
1000ppmbutnotat500ppm, decreasedperformance oncognitive
task at 2000 ppm but not at 500 ppm and below, changes in
neurotransmitters at 80 ppm and above
Chronic exposure
Transient decrease in sleep, increase in activity and drinking,
changes in neurotransmitters at 200 mg/kg/day IP, changes in
neurotransmitters at air concentrations above 50 ppm, increased
activity and motor incoordination after developmental exposure
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ofethanol exposure are coughing, eye and nose irritation,
which appear at a concentration of approximately 5,000-
10,000 ppm. At about 15,000 ppm, these symptoms
increase, and continuous lachrymation and coughing
occur. Concentrations of 20,000 ppm and above were
judged asintolerable (83). Inrodents, constant exposure to
airconcentrations ofethanolfrom7,500 ppmto15,000 ppm
for4-10daysproduces signs ofalcoholintoxication, depen-
dency, and withdrawal. Pregnant rats exposed to air con-
centrations ofethanol at16,000 ppm or20,000 ppm exhibit
signs ofintoxication andreducedweightgain. Twenty-day-
old fetuses ofdams exposed at the 20,000 ppm concentra-
tion exhibited a significant increase in visceral and/or
skeletal malformations. Rats exposed to 10,000 ppm
showed no maternal or fetal effects (84-87).
The developmental deficits associated with fetal alcohol
syndrome (FAS) and fetal alcohol effects (FAE), aswell as
"social drinking" during pregnancy, havebeen thetopic of
numerous publications. FAS and FAE infants display
increased irritability, tremulousness, and reduced weight
gain. Olderchildrendisplayincreased socialandemotional
problems and intellectual impairment that may continue
into adulthood. Offspring of social-drinking women dis-
play lower birthweights, abnormal state regulation, lower
scores on infant developmental tests, growth retardation,
increased restlessness, short attention span, and motor
dysfunction. The pattern of alcohol consumption most
related to the effects observed in offspring of social
drinkers is more than two drinks/day during midpreg-
nancyandbinge drinking(morethanfivedrinks/occasion)
in the months just before pregnancy recognition (88-91).
Several animal models have been developed to replicate
the behavioral findings reported for humans (92). In addi-
tion, studies using animal models have investigated the
neuroanatomical and neurochemical effects of prenatal
alcohol exposure. Most ofthe studies concerning the neu-
rochemical effects have focused on the GABAergic system
(93,94). The results of these studies, however, have not
provided a consistent pattern ofeffects. Theinconsistency
may be due to a biphasic dose-dependent response of
GABA to ethanol. Results indicate that glutamine and
GABA increase at low-level exposure (2 g/kg ethanol) but
decrease athigher exposure concentrations (3 and 8 g/kg)
(94). Not all studies on the neurochemical effects ofalcohol
have focused on the GABAergic system. Rats intubated
with 4 g/kg ethanol every 12 hr for 11-15 days exhibited a
significant reduction in the binding of mesolimbic
dopamine receptors (20%). Thebindingofserotonin recep-
tors was significantlyincreased in the striatum (63%) and
brainstem (32%) and was significantly decreased in the
hippocampus (20%). The binding of acetylcholine recep-
tors was also significantly increased in the striatum (7%)
and significantly decreased in the cerebral cortex (5%) (95).
Finally, recent results from studies of nonhuman primate
infants exposed to weekly doses of ethanol have provided
some data regarding prenatal alcohol effects. Micro-
phthalmia, retinal ganglion cell loss, and altered striatal
dopamine concentrations have been reported thus far (96).
A summary of the neurotoxic effects reported for eth-
anol is shown in Table 7. Thus far, the most sensitive
Table 7. Summary ofthe neurotoxic effects ofethanol.
Humans
Alcoholism
Ataxia, dysarthria, dementia, amnesia, peripheral-nerve disorders,
cerebellar and cortical lesions
Developmental exposure
Fetal alcohol effects observed atexposureto > 1 oz absolute alcohol/
day
Animals
Chronic exposure
Alcohol intoxication, dependence and withdrawal at air concentra-
tions from 7500 ppm to 15,000 ppm, intoxication and reduced
weight gain at maternal exposure of16,000 ppm but not at 10,000
ppm, changes in neurochemistry at doses from 2 to 8 g/kg,
microphthalmia, retinal ganglion cell loss, altered dopamine con-
centrations after maternal "binge" drinking
indexes of alcohol exposure effects are those observed
aftermaternalalcoholintakeduringpregnancy. Offspring
effects on behavior have been reported at blood alcohol
concentrations associated with the intake of > 1 oz of
absolute alcohol per day.
Discussion
Determining the neurotoxic effects associated with
chronic low-level occupational orenvironmental exposures
requires dose-response data for several neurotoxic end
points from well-designed studies. Data may come from
studies ofoccupational exposure ofworkers, studies using
animal models and, for some compounds, studies from
controlled exposures in the laboratory. The studies should
include several exposure levels and procedures for deter-
mining a NOAEL. Studies of occupational exposure and
effects should include a complete work history, neurologi-
cal examination, and neuropsychological test battery of
the workers, measures ofworkplace (and other potential)
exposures, and procedures for estimating internal dose.
Thestudies shouldincludeanappropriatecontrolgroupas
well as sufficient exposed workers for a dose-response
analysis. Studies using animal models should focus on
subtle neurotoxic effects after chronic low-level exposure
and include procedures for assessing the effects of expo-
sure onbehavior, neuroanatomy, andneurochemistry. Pro-
cedures for examining the transient or permanent nature
of the effects should be used. Studies of both adults and
developing animals should be performed because the
effects from developmental exposures may be different
from those observed in adult animals.
This report provides an overview of studies that are
availablefortheevaluation oftheneurotoxiceffects associ-
ated with chronic low-level exposure to gasoline and cer-
tain gasoline constituents. In general, the occupational
studies of these compounds do not even meet the first
criterion discussed above because most do not include
measuresofworkplaceexposures. Fortoluene,xylene,and
methanol, studies ofcontrolled laboratory exposures indi-
cate neurologic effects near or below the current TLV.
Although these effects may be transient, they can influ-
ence workplace safety. In addition, the long-term conse-
quences ofthese effects have not been studied.
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Little dose-response data are available from studies
using animal models. Many of the studies examined only
one dose level. Results from other studies sometimes
provideddatafordeterminingaNOAELbutonlyforsigns
of overt neurotoxicity. In general, data for determining a
NOAEL for more subtle neurotoxic effects (e.g., learning
and memory) are not available. Finally, exceptforethanol,
none ofthe compounds hasbeen studied extensivelyusing
a developmental approach.
Afew general conclusions and recommendations can be
made based on the results ofthe studies to date. a) All of
the compounds reviewed are neuroactive and, as such,
should be examined for their neurotoxicity. b) For most of
the compounds, there is a substantial margin of safety
betweenthecurrentpermissible exposurelevels andlevels
that would be expected to cause overt signs of neurotox-
icityinhumans.Thisisnotthecaseforxylene,toluene,and
methanol, however, where neurologic effects are observed
atorbelowthe currentTLV. c) Formostofthecompounds,
the relationship between chronic low-level exposure and
subtle neurotoxic effects has not been studied. Studies,
therefore, should focus on examining the dose-response
relationshipbetween chroniclow-level exposure and subtle
changes in central nervous system function. d) Limited
dataareavailableconcerningtheneurotoxiceffectsassoci-
ated with exposure to MTBE, ETBE, and TAME. The
extensive use of MTBE in gasoline is a relatively new
development. The use of ETBE and TAME remains low
but is expected to rise. Additional studies of these com-
pounds should be prioritized because they seem to repre-
sent the future for reformulated gasoline. e) Except for
ethanol, few studies are available concerning thepotential
developmental neurotoxicity of the compounds. Further
studies should be developed focusing on this issue. These
studies should follow the guidelines recently published by
the EPA for testing potential developmental neurotoxic
compounds.
The author thanks Jacqueline Smith, Peter Spencer, and Hugh Tilson
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